false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Skip Navigation Links
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Menu
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Hamburger Menu
Catalog
Calendar
Help
Catalog
Study 309/Keynote-775: A Randomized, Phase 3 Study ...
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
Description
Recorded Live: May 10, 2022
Presenter
Vicky Makker, MD
USA
Summary
Availability:
On-Demand
Cost:
FREE
×
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
Multidisciplinary Approach to Treating Advanced Endometrial Cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
An Evolving Frontier: Endometrial Cancer Treatment
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Preinvasive Disease Program
Preinvasive Disease Program is an IGCS member benefit.
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Moving Towards Personalized Therapy in Endometrial Cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Emerging data in platinum resistance advanced ovarian cancer - Webinar
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
International Gynecologic Cancer Society and International Journal of Gynecological Cancer Evidence-Based Medicine for Gynecological Oncology Curriculum (EBM on the GO)
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Selinexor in Maintenance Therapy After Systemic Therapy for Patients with p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma: XPORT-042 - Trial in Progress
FREE
Login
User Login
Continue with Google
OR
Login Name
Required
Password
Required
Logging In…
Create Account
Forgot Password
Contact
education@igcs.org
for assistance.
×